The CDC has acknowledged that antibody tests used to determine if people have previously been infected with Covid-19 are not accurate enough to guide important policy decisions.
Fearful of a secondary wave of coronavirus infections coinciding with flu season, drugmakers and pharmacies are proactively preparing for a significant increase in demand for flu vaccinations this fall.